Schubert C, Parwaresch R, Rudolph P
Institute of Dermatology and Dermatopathology, Buchholz, Germany.
Virchows Arch. 2001 Feb;438(2):166-72. doi: 10.1007/s004280000340.
Clinically and histologically, the concept of dysplastic nevi remains controversial. To elaborate more precise criteria for the nevi of patients with dysplastic naevus syndrome (DNS), we examined 58 nevi from seven DNS patients who developed one or several malignant melanomas. Clinical presentation and histomorphology were evaluated, and immunohistochemistry was performed using proliferation marker Ki-S5 and antibody DO-7 to the p53 protein. Sixty nevi from individuals without history of melanoma served as controls. Of the DNS nevi, 21 (36.2%) exhibited no morphological particularities. The remaining 37 nevi presented distinctive histological features consisting of a slight epidermal acanthosis, spitzoid vertically oriented nests of dyscohesive nevus cells, and single-standing atypical melanocytes in the basal cell layer of the epidermis. Immunohistochemical analysis revealed an average proliferation index of 2.5%, which significantly surpassed the mean growth fraction of conventional dysplastic nevi (<1%). No increase in p53 expression was observed. Characteristically, active proliferation was found in junctional single-standing melanocytes with or without nuclear atypia rather than in nest-shaped compounds. In conclusion, certain moles of patients with DNS possess distinctive features. The newly characterized criteria may provide a basis for the diagnosis of DNS and might help to identify patients at increased risk for malignant melanoma by examination of a single biopsy.
在临床和组织学上,发育异常痣的概念仍存在争议。为了阐述发育异常痣综合征(DNS)患者痣的更精确标准,我们检查了7例发生1例或多例恶性黑色素瘤的DNS患者的58颗痣。评估了临床表现和组织形态学,并使用增殖标记物Ki-S5和针对p53蛋白的抗体DO-7进行了免疫组织化学检测。来自无黑色素瘤病史个体的60颗痣作为对照。在DNS痣中,21颗(36.2%)未表现出形态学特殊性。其余37颗痣呈现出独特的组织学特征,包括轻微的表皮棘皮症、发育异常痣细胞的梭形垂直排列巢状结构,以及表皮基底层中单个存在的非典型黑素细胞。免疫组织化学分析显示平均增殖指数为2.5%,显著超过传统发育异常痣的平均生长分数(<1%)。未观察到p53表达增加。特征性地,在有或无核异型性的交界性单个存在的黑素细胞中发现活跃增殖,而非巢状结构中。总之,DNS患者的某些痣具有独特特征。新确定的标准可为DNS的诊断提供依据,并可能有助于通过对单个活检标本的检查来识别恶性黑色素瘤风险增加的患者。